Capital Group Private Client Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Buy
+30,302
New +$2.02M 0.03% 160
2023
Q4
Sell
-23,200
Closed -$2.16M 252
2023
Q3
$2.16M Hold
23,200
0.03% 179
2023
Q2
$2.98M Buy
23,200
+256
+1% +$31K 0.04% 164
2023
Q1
$2.67M Hold
22,944
0.03% 161
2022
Q4
$2.6M Hold
22,944
0.03% 168
2022
Q3
$1.85M Hold
22,944
0.03% 177
2022
Q2
$1.71M Hold
22,944
0.02% 182
2022
Q1
$2.94M Buy
+22,944
New +$2.51M 0.03% 179

Other funds holding DXCM

Capital Group Private Client Services's DXCM Position: Q2 2026 in Review

Capital Group Private Client Services opened a new position in DexCom (DXCM) in Q2 2026: 30,302 shares worth $2.04M. The stake represents 0.03% of the portfolio and ranks #160 among its holdings. This is a return to the name: Capital Group Private Client Services previously reported a position in DXCM as recently as Q3 2023.

Capital Group Private Client Services first reported a position in DXCM in Q1 2022 and has held it in 8 quarters since. The position peaked at $2.98M in Q2 2023. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Capital Group Private Client Services held 30,302 shares of DexCom worth $2.04M as of Q2 2026.
  • DexCom was a new Capital Group Private Client Services position in Q2 2026.
  • DexCom made up 0.03% of Capital Group Private Client Services's portfolio in Q2 2026, its #160 holding.
  • Capital Group Private Client Services first reported a position in DexCom in Q1 2022 and has held it in 8 quarters since.
  • Capital Group Private Client Services's DexCom position peaked at $2.98M in Q2 2023.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Capital Group Private Client Services's 13F filing for Q2 2026, filed 12 Aug 2026.